<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>Conclusions: Ocular elastography can be performed using acombination of phase-sensitive OCT and air pulse stimulation. Thismethod can detect low amplitude tissue excitation, which can be usedto quantify corneal stiffness.Commercial Relationships: Michael D. Twa, None; Jiasong Li,None; Ravi Kiran Manapuram, Bioptigen Inc., (E); Floredes M.Menodiado, None; Salavat Aglyamov, None; Stanislav Emelianov,None; Kirill Larin, NoneSupport: EY022362Program Number: 1613 Poster Board Number: D0248Presentation Time: 8:30 AM - 10:15 AMThe Rigidity of <strong>Cornea</strong>s before and after <strong>Cornea</strong>l Cross-linking -as measured by Corvis® STSashia Bak-Nielsen, Iben Bach Pedersen, Anders Ivarsen, JesperHjortdal. Ophthalmology, Aarhus University Hospital, Aarhus,Denmark.Purpose: <strong>Cornea</strong>l Cross-linking (CXL) for treating keratoconus hasbeen shown to stiffen the cornea in vitro and clinical studies havedocumented that progression of keratoconus is halted in most cases.The Corvis ST from Oculus dynamically measures cornealdeformation by Scheimpflug imaging during an air puff. The patternof deformation theoretically depends on the intraocular pressure, thecorneal thickness and the material properties of the cornea. Thepurpose of this study was to measure the possible stiffening effect ofCXL on patients with keratoconus, comparing groups with andwithout a previous CXL procedure.Methods: Thirty-seven keratoconus patients were included- 19 with untreated keratoconus- 18 with keratoconus treated with CXL 4-50 months previously(median 27 months)Furthermore 31 healthy subjects were included as a control group.Apart from being measured with Corvis ST the subjects underwent afull ophthalmic examination including Pentacam topography. ThePentacam measurements were used to stage the patients into 4 groupsbased on the severity of the keratoconus. The stiffness of the corneawas evaluated by the radius of corneal concavity at the maximumdeformation (DR) as calculated by the Corvis ST.Results: There was no significant difference in DR between theuntreated keratoconus group and the CXL treated group although DRappeared marginally larger in eyes that had underwent CXL (unpairedt-test, p>0.05, Table 1). Increasing keratoconus severity(Grades 1-4) had only a small and insignificant influence on DR(ANOVA, p>0.05). DR in untreated and CXL treated keratoconusgroups was significantly smaller compared with normal eyes.Conclusions: Eyes with keratoconus have a smaller DR as measuredby the Corvis ST, but the DR was similar in untreated and CXLtreated eyes. As the effect of CXL mainly is exerted in the anteriorpart of the corneal stroma, it can be speculated that DR is insensibleto changes in corneal material properties in the anterior stroma.Further studies of corneal deformation parameters in the samepatients before and after CXL are needed to further evaluate theCorvis ST and the effect of CXL.Table 1: Mean DR and 95% Confidence interval (CI) for keratoconuseyes (grade 1-4), CXL treated eyes (grade 1-4) and normal eyesCommercial Relationships: Sashia Bak-Nielsen, None; Iben BachPedersen, None; Anders Ivarsen, None; Jesper Hjortdal, CarlZeiss Meditec (R)Program Number: 1614 Poster Board Number: D0249Presentation Time: 8:30 AM - 10:15 AMAssociation of Ambient Solar Radiation with BiomechanicalProperties of the <strong>Cornea</strong> In an elderly population: The AlienorStudyCedric Schweitzer 1 , Cecile Delcourt 2 , Florence Malet 1 , Melanie LeGoff 2 , Jean-Francois Korobelnik 1, 2 , Marie B. Rougier 1 , Marie-NoelleDelyfer 1, 2 , Jean Francois Dartigues 2 , Pascale Barberger-gateau 2 ,Joseph Colin 1 . 1 Ophthalmology, University Hospital Pellegrin,Bordeaux, France; 2 INSERM, ISPED, Bordeaux university,bordeaux, France.Purpose: To analyze the association of ambient solar radiation (SR)on biomechanical properties of the cornea in adult patients.Methods: The ALIENOR (Antioxydants, Lipides Essentiels,Nutrition and maladies OculaiRes) Study is a population-basedepidemiological study on age-related eye diseases. In 2009-2010, 625subjects, aged 75 years or more, had an eye examination, includingintraocular pressure, central corneal thickness (CCT) measurements,and an evaluation of the biomechanical properties of the cornea usingthe ocular response analyser® (ORA®, reichert inc., USA). Meanlifetime ambient SR was estimated using residential history. Globalambient annual SR (a measure of solar energy including allwavelengths) was estimated using astronomic formulas and thestatistics of sunshine hours at each location. Then, for eachparticipant, average annual ambient SR was estimated by weightingannual ambient solar radiation at each location by the time spent atthat location. Participants were classified in 3 groups (Group 1:474.74 kJ/cm2). <strong>Cornea</strong>l hysteresis (CH), corneal resistancefactor (CRF), corneal compensated intraocular pressure (IOPcc),Goldmann correlated intraocular pressure (IOPg) and CCTparameters were analyzed between SR groups, using mixed linearregression models taking into account data from both eyes and theirintra-individual correlations.Results: After adjustment for age and gender, there was a significantassociation of CH and CRF values with SR higher than 474.74kJ/cm2 (CH: -0.39mmHg, 95% confidence interval (CI): -0.75;-0.03,p=0.03/ CRF: -0.38mmHg, 95% CI: -0.74; -0.03, p=0.035), whereasthere was no significant association of CH and CRF values with SRlower than 458.53 kJ/cm2 (CH: 0.01mmHg, 95% CI: -0.34; 0.36,p=0.96/ CRF: 0.002mmHg, 95% CI: -0.35; 0.35, p=0.99). The CCTwas not significantly associated with SR ( SR 474.74: CCT: -4.25µm, 95%CI: -13.86;5.35, p=0.38).Conclusions: CH and CRF were significantly lower in subjectsexposed to high ambient solar radiation. Ambient UV exposure mightinduce histological changes of the cornea that influence itsbiomechanical properties.Commercial Relationships: Cedric Schweitzer, None; CecileDelcourt, Laboratoires Théa (F), Novartis (C), Bausch+Lomb (C);Florence Malet, None; Melanie Le Goff, None; Jean-FrancoisKorobelnik, Alcon (C), Allergan (C), Bayer (C), Carl Zeiss Meditec(C), Novartis (C), Thea (F); Marie B. Rougier, THEA (C),Bausch&Lomb (C), Allergan (C), Kemin (C); Marie-Noelle Delyfer,Thea Laboratories (F); Jean Francois Dartigues, Novartis (F),IPSEN (F); Pascale Barberger-gateau, Danone (F), Vifor Pharma(C); Joseph Colin, Alcon (C), Abbott (C), AdditionTechnology (C)Support: Laboratoires Théa, Fondation Voir et Entendre©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the <strong>ARVO</strong> Office at arvo@arvo.org.
<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>Program Number: 1615 Poster Board Number: D0250Presentation Time: 8:30 AM - 10:15 AMEffect of UVA-Rb cross-linking on through-thickness strains incanine corneasJoel Palko 1 , Xueliang Pan 2 , Jun Liu 3, 4 . 1 Wexner Medical Center,Ohio State University, Columbus, OH; 2 Center for Biostatistics, OhioState University, Columbus, OH; 3 Deprtment of BiomedicalEngineering, Ohio State University, Columbus, OH; 4 Department ofOphthalmology, Ohio State University, Columbus, OH.Purpose: Monitoring the mechanical changes of the cornea beforeand after corneal cross linking (CXL) provides valuable insight intoCXL mechanisms and may help provide more personalized treatmentplans for this therapy in the prevention of progressive keratoconus.The purpose of this study was to measure through-thickness strains inthe cornea at physiologic IOPs before and after CXL using noninvasiveultrasound.Methods: The anterior 3/4 of paired canine corneoscleral shellsincluding a CXL treated group (n=6) and a control group (n=6) weremounted to a pressurization chamber within 10hrs of euthaniasia. TheCXL group completed a standard clinical CXL protocol usingriboflavin (Rb solution and UVA radiation (370nm, irradiance3mW/cm2). Control eyes were given an identical Rb treatmentwithout UVA irradiation. <strong>Cornea</strong> ultrasound scans (at 55 MHz) alongthe nasal-temporal (NT) and superior-inferior (SI) cross-sectionswere obtained before and after treatment as IOP was graduallyincreased from 5 mmHg to 45mmHg. Strain tracking was performedusing a previously validated method (Tang & Liu, J. Biomech. Engrg2012, 134(9)). Mean radial compressive strains and tangential tensilestrains were calculated for the anterior, middle, and posterior onethirds of the cornea thickness in the nasal-temporal (NT) andsuperior-inferior (SI) directions. Mean strains at IOPs of 10, 20, and30mmHg were compared between the CXL and control groups usingmixed linear models with repeated measures.Results: Statistically significant reductions in tensile andcompressive strains were found in the SI orientation at all three IOPsand all three layers in the CXL group (all p0.05). The anterior third appeared to have larger tensile strainreduction than the posterior layer in the CXL group.Conclusions: Ultrasound strain tracking revealed that the Rb-UVACXL procedure significantly reduced corneal strains (i.e., stiffenedthe cornea) during physiologic IOP elevation with more pronouncedeffects observed in the anterior cornea. The ability to measure andmonitor cornea strains may provide insight into the biomechanicaleffects of CXL and better define its role as a treatment for certainocular disorders.Commercial Relationships: Joel Palko, None; Xueliang Pan,None; Jun Liu, NoneSupport: NIHRO1EY020929 (JL), Ohio State University College ofMedicine (JP)Program Number: 1616 Poster Board Number: D0251Presentation Time: 8:30 AM - 10:15 AMIn Vivo Evaluation of <strong>Cornea</strong>l Biomechanical Properties After<strong>Cornea</strong>l Collagen Cross-linking TherapyRaksha Urs 1 , Harriet Lloyd 1 , Ronald H. Silverman 1, 2 .1 Ophthalmology, Columbia University Medical Center, New York,NY; 2 Frederic L. Lizzi Center for Biomedical Engineering, RiversideResearch Institute, New York, NY.Purpose: Collagen cross-linking therapy (CXL) is emerging as atreatment option for keratoconus. This procedure strengthens thebiomechanical properties of the cornea by cross-linking the collagenbonds. However, biomechanical tests, to evaluate CXL outcome,have been performed only on ex vivo tissue. In vivo, the efficacy ofthe treatment is verified by assessing vision quality. The objective ofthis project is to demonstrate an in vivo technique to determinedifference in biomechanical strength of the cornea after CXL.Methods: CXL procedure was performed on the right eyes of 6rabbits. The left eyes were used as controls. Acoustic Radiation Force(ARF) was used to assess corneal stiffness in vivo, once beforetreatment (Baseline BL) and weekly for four weeks after treatment(W1-W4). <strong>Cornea</strong> was exposed to ARF using a single elementtransducer (25 MHz central frequency; 6 mm aperture; 18 mm focallength; Panametrics V324-SU). The beam sequence consisted of 20pushing tonebursts of 400 μs duration (80% duty cycle). Imagingimpulses were interleaved in the dead time to allow the sametransducer to acquire radiofrequency data during the push mode toimage corneal displacement. Acoustic power levels were withinFDA-specified levels for ophthalmic safety. Displacement of thefront and back surfaces of the cornea were used to determine thechange in corneal thickness and strain. ARF induced strain was fit tothe Kelvin-Voigt model to determine the elastic modulus. Theaverage moduli were calculated for the six rabbits, for each of thefive time points (BL, W1-W4).Results: At the end of four weeks, ARF measurements showed anincrease of average elastic modulus by 33% in the treated eye, and3% in the control eye. Paired t-tests revealed statistically significantdifferences between treated and untreated eyes from W1-W4(p=0.0005, 0.04, 0.0007, 0.006). There was no significant differencebetween right and left eyes before treatment (p=0.95).Conclusions: Our findings demonstrate statistically significantdifferences in stiffness between control and CXL-treated rabbitcorneas in vivo based on axial stress/strain measurements obtainedusing ARF. The capacity to non-invasively monitor corneal stiffnessoffers the potential for clinical monitoring of CXL. Longer term©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the <strong>ARVO</strong> Office at arvo@arvo.org.
- Page 2 and 3:
ARVO 2013 Annual Meeting Abstracts
- Page 4 and 5:
ARVO 2013 Annual Meeting Abstracts
- Page 6 and 7:
ARVO 2013 Annual Meeting Abstracts
- Page 8 and 9:
ARVO 2013 Annual Meeting Abstracts
- Page 10:
ARVO 2013 Annual Meeting Abstracts
- Page 13 and 14:
ARVO 2013 Annual Meeting Abstracts
- Page 16 and 17:
ARVO 2013 Annual Meeting Abstracts
- Page 18 and 19:
ARVO 2013 Annual Meeting Abstracts
- Page 20 and 21:
ARVO 2013 Annual Meeting Abstracts
- Page 22 and 23:
ARVO 2013 Annual Meeting Abstracts
- Page 24 and 25:
ARVO 2013 Annual Meeting Abstracts
- Page 26 and 27:
ARVO 2013 Annual Meeting Abstracts
- Page 28 and 29:
ARVO 2013 Annual Meeting Abstracts
- Page 30 and 31:
ARVO 2013 Annual Meeting Abstracts
- Page 32 and 33:
ARVO 2013 Annual Meeting Abstracts
- Page 34 and 35:
ARVO 2013 Annual Meeting Abstracts
- Page 36 and 37:
ARVO 2013 Annual Meeting Abstracts
- Page 38 and 39:
ARVO 2013 Annual Meeting Abstracts
- Page 40 and 41: ARVO 2013 Annual Meeting Abstracts
- Page 42 and 43: ARVO 2013 Annual Meeting Abstracts
- Page 44 and 45: ARVO 2013 Annual Meeting Abstracts
- Page 46 and 47: ARVO 2013 Annual Meeting Abstracts
- Page 48 and 49: ARVO 2013 Annual Meeting Abstracts
- Page 50 and 51: ARVO 2013 Annual Meeting Abstracts
- Page 52 and 53: ARVO 2013 Annual Meeting Abstracts
- Page 54 and 55: ARVO 2013 Annual Meeting Abstracts
- Page 56 and 57: ARVO 2013 Annual Meeting Abstracts
- Page 58 and 59: ARVO 2013 Annual Meeting Abstracts
- Page 60 and 61: ARVO 2013 Annual Meeting Abstracts
- Page 62 and 63: ARVO 2013 Annual Meeting Abstracts
- Page 64 and 65: ARVO 2013 Annual Meeting Abstracts
- Page 66 and 67: ARVO 2013 Annual Meeting Abstracts
- Page 68 and 69: ARVO 2013 Annual Meeting Abstracts
- Page 70 and 71: ARVO 2013 Annual Meeting Abstracts
- Page 72 and 73: ARVO 2013 Annual Meeting Abstracts
- Page 74 and 75: ARVO 2013 Annual Meeting Abstracts
- Page 76 and 77: ARVO 2013 Annual Meeting Abstracts
- Page 78 and 79: ARVO 2013 Annual Meeting Abstracts
- Page 80 and 81: ARVO 2013 Annual Meeting Abstracts
- Page 82 and 83: ARVO 2013 Annual Meeting Abstracts
- Page 84 and 85: ARVO 2013 Annual Meeting Abstracts
- Page 86 and 87: ARVO 2013 Annual Meeting Abstracts
- Page 88 and 89: ARVO 2013 Annual Meeting Abstracts
- Page 92 and 93: ARVO 2013 Annual Meeting Abstracts
- Page 94 and 95: ARVO 2013 Annual Meeting Abstracts
- Page 96 and 97: ARVO 2013 Annual Meeting Abstracts
- Page 98 and 99: ARVO 2013 Annual Meeting Abstracts
- Page 100 and 101: ARVO 2013 Annual Meeting Abstracts
- Page 102 and 103: ARVO 2013 Annual Meeting Abstracts
- Page 104 and 105: ARVO 2013 Annual Meeting Abstracts
- Page 106 and 107: ARVO 2013 Annual Meeting Abstracts
- Page 108 and 109: ARVO 2013 Annual Meeting Abstracts
- Page 110 and 111: ARVO 2013 Annual Meeting Abstracts
- Page 112 and 113: ARVO 2013 Annual Meeting Abstracts
- Page 114 and 115: ARVO 2013 Annual Meeting Abstracts
- Page 116 and 117: ARVO 2013 Annual Meeting Abstracts
- Page 118 and 119: ARVO 2013 Annual Meeting Abstracts
- Page 120 and 121: ARVO 2013 Annual Meeting Abstracts
- Page 122 and 123: ARVO 2013 Annual Meeting Abstracts
- Page 124 and 125: ARVO 2013 Annual Meeting Abstracts
- Page 126 and 127: ARVO 2013 Annual Meeting Abstracts
- Page 128 and 129: ARVO 2013 Annual Meeting Abstracts
- Page 130 and 131: ARVO 2013 Annual Meeting Abstracts
- Page 132 and 133: ARVO 2013 Annual Meeting Abstracts
- Page 134 and 135: ARVO 2013 Annual Meeting Abstracts
- Page 136 and 137: ARVO 2013 Annual Meeting Abstracts
- Page 138 and 139: ARVO 2013 Annual Meeting Abstracts
- Page 140 and 141:
ARVO 2013 Annual Meeting Abstracts
- Page 142 and 143:
ARVO 2013 Annual Meeting Abstracts
- Page 144 and 145:
ARVO 2013 Annual Meeting Abstracts
- Page 146 and 147:
ARVO 2013 Annual Meeting Abstracts
- Page 148 and 149:
ARVO 2013 Annual Meeting Abstracts
- Page 150 and 151:
ARVO 2013 Annual Meeting Abstracts
- Page 152 and 153:
ARVO 2013 Annual Meeting Abstracts
- Page 154 and 155:
ARVO 2013 Annual Meeting Abstracts
- Page 156 and 157:
ARVO 2013 Annual Meeting Abstracts
- Page 158 and 159:
ARVO 2013 Annual Meeting Abstracts
- Page 160 and 161:
ARVO 2013 Annual Meeting Abstracts
- Page 162 and 163:
ARVO 2013 Annual Meeting Abstracts
- Page 164 and 165:
ARVO 2013 Annual Meeting Abstracts
- Page 166 and 167:
ARVO 2013 Annual Meeting Abstracts
- Page 168 and 169:
ARVO 2013 Annual Meeting Abstracts
- Page 170 and 171:
ARVO 2013 Annual Meeting Abstracts
- Page 172 and 173:
ARVO 2013 Annual Meeting Abstracts
- Page 174 and 175:
ARVO 2013 Annual Meeting Abstracts
- Page 176 and 177:
ARVO 2013 Annual Meeting Abstracts
- Page 178 and 179:
ARVO 2013 Annual Meeting Abstracts
- Page 180 and 181:
ARVO 2013 Annual Meeting Abstracts
- Page 182 and 183:
ARVO 2013 Annual Meeting Abstracts
- Page 184 and 185:
ARVO 2013 Annual Meeting Abstracts
- Page 186 and 187:
ARVO 2013 Annual Meeting Abstracts
- Page 188 and 189:
ARVO 2013 Annual Meeting Abstracts
- Page 190 and 191:
ARVO 2013 Annual Meeting Abstracts
- Page 192 and 193:
ARVO 2013 Annual Meeting Abstracts
- Page 194 and 195:
ARVO 2013 Annual Meeting Abstracts
- Page 196 and 197:
ARVO 2013 Annual Meeting Abstracts
- Page 198 and 199:
ARVO 2013 Annual Meeting Abstracts
- Page 200 and 201:
ARVO 2013 Annual Meeting Abstracts
- Page 202 and 203:
ARVO 2013 Annual Meeting Abstracts
- Page 204 and 205:
ARVO 2013 Annual Meeting Abstracts
- Page 206 and 207:
ARVO 2013 Annual Meeting Abstracts
- Page 208 and 209:
ARVO 2013 Annual Meeting Abstracts
- Page 210 and 211:
ARVO 2013 Annual Meeting Abstracts
- Page 212 and 213:
ARVO 2013 Annual Meeting Abstracts
- Page 214 and 215:
ARVO 2013 Annual Meeting Abstracts
- Page 216 and 217:
ARVO 2013 Annual Meeting Abstracts
- Page 218 and 219:
ARVO 2013 Annual Meeting Abstracts
- Page 220 and 221:
ARVO 2013 Annual Meeting Abstracts
- Page 222 and 223:
ARVO 2013 Annual Meeting Abstracts
- Page 224 and 225:
ARVO 2013 Annual Meeting Abstracts
- Page 226 and 227:
ARVO 2013 Annual Meeting Abstracts
- Page 228 and 229:
ARVO 2013 Annual Meeting Abstracts
- Page 230 and 231:
ARVO 2013 Annual Meeting Abstracts
- Page 232 and 233:
ARVO 2013 Annual Meeting Abstracts
- Page 234 and 235:
ARVO 2013 Annual Meeting Abstracts
- Page 236 and 237:
ARVO 2013 Annual Meeting Abstracts
- Page 238 and 239:
ARVO 2013 Annual Meeting Abstracts
- Page 240 and 241:
ARVO 2013 Annual Meeting Abstracts
- Page 242 and 243:
ARVO 2013 Annual Meeting Abstracts
- Page 244 and 245:
ARVO 2013 Annual Meeting Abstracts
- Page 246 and 247:
ARVO 2013 Annual Meeting Abstracts
- Page 248 and 249:
ARVO 2013 Annual Meeting Abstracts
- Page 250 and 251:
ARVO 2013 Annual Meeting Abstracts
- Page 252 and 253:
ARVO 2013 Annual Meeting Abstracts
- Page 254 and 255:
ARVO 2013 Annual Meeting Abstracts
- Page 256 and 257:
ARVO 2013 Annual Meeting Abstracts
- Page 258 and 259:
ARVO 2013 Annual Meeting Abstracts
- Page 260 and 261:
ARVO 2013 Annual Meeting Abstracts
- Page 262 and 263:
ARVO 2013 Annual Meeting Abstracts
- Page 264 and 265:
ARVO 2013 Annual Meeting Abstracts
- Page 266 and 267:
ARVO 2013 Annual Meeting Abstracts
- Page 268 and 269:
ARVO 2013 Annual Meeting Abstracts
- Page 270 and 271:
ARVO 2013 Annual Meeting Abstracts
- Page 272 and 273:
ARVO 2013 Annual Meeting Abstracts
- Page 274 and 275:
ARVO 2013 Annual Meeting Abstracts
- Page 276 and 277:
ARVO 2013 Annual Meeting Abstracts
- Page 278 and 279:
ARVO 2013 Annual Meeting Abstracts
- Page 280 and 281:
ARVO 2013 Annual Meeting Abstracts
- Page 282 and 283:
ARVO 2013 Annual Meeting Abstracts
- Page 284 and 285:
ARVO 2013 Annual Meeting Abstracts
- Page 286 and 287:
ARVO 2013 Annual Meeting Abstracts
- Page 288 and 289:
ARVO 2013 Annual Meeting Abstracts
- Page 290 and 291:
ARVO 2013 Annual Meeting Abstracts
- Page 292 and 293:
ARVO 2013 Annual Meeting Abstracts
- Page 294 and 295:
ARVO 2013 Annual Meeting Abstracts
- Page 296 and 297:
ARVO 2013 Annual Meeting Abstracts
- Page 298 and 299:
ARVO 2013 Annual Meeting Abstracts
- Page 300 and 301:
ARVO 2013 Annual Meeting Abstracts
- Page 302 and 303:
ARVO 2013 Annual Meeting Abstracts
- Page 304 and 305:
ARVO 2013 Annual Meeting Abstracts
- Page 306 and 307:
ARVO 2013 Annual Meeting Abstracts
- Page 308 and 309:
ARVO 2013 Annual Meeting Abstracts
- Page 310 and 311:
ARVO 2013 Annual Meeting Abstracts
- Page 312 and 313:
ARVO 2013 Annual Meeting Abstracts
- Page 314 and 315:
ARVO 2013 Annual Meeting Abstracts
- Page 316 and 317:
ARVO 2013 Annual Meeting Abstracts
- Page 318 and 319:
ARVO 2013 Annual Meeting Abstracts
- Page 320 and 321:
ARVO 2013 Annual Meeting Abstracts
- Page 322 and 323:
ARVO 2013 Annual Meeting Abstracts
- Page 324 and 325:
ARVO 2013 Annual Meeting Abstracts
- Page 326 and 327:
ARVO 2013 Annual Meeting Abstracts
- Page 328 and 329:
ARVO 2013 Annual Meeting Abstracts
- Page 330 and 331:
ARVO 2013 Annual Meeting Abstracts
- Page 332 and 333:
ARVO 2013 Annual Meeting Abstracts
- Page 334 and 335:
ARVO 2013 Annual Meeting Abstracts
- Page 336 and 337:
ARVO 2013 Annual Meeting Abstracts
- Page 338 and 339:
ARVO 2013 Annual Meeting Abstracts
- Page 340 and 341:
ARVO 2013 Annual Meeting Abstracts
- Page 342 and 343:
ARVO 2013 Annual Meeting Abstracts
- Page 344 and 345:
ARVO 2013 Annual Meeting Abstracts
- Page 346 and 347:
ARVO 2013 Annual Meeting Abstracts
- Page 348 and 349:
ARVO 2013 Annual Meeting Abstracts
- Page 350 and 351:
ARVO 2013 Annual Meeting Abstracts
- Page 352 and 353:
ARVO 2013 Annual Meeting Abstracts
- Page 354 and 355:
ARVO 2013 Annual Meeting Abstracts
- Page 356 and 357:
ARVO 2013 Annual Meeting Abstracts
- Page 358 and 359:
ARVO 2013 Annual Meeting Abstracts
- Page 360 and 361:
ARVO 2013 Annual Meeting Abstracts
- Page 362 and 363:
ARVO 2013 Annual Meeting Abstracts
- Page 364 and 365:
ARVO 2013 Annual Meeting Abstracts
- Page 366 and 367:
ARVO 2013 Annual Meeting Abstracts
- Page 368 and 369:
ARVO 2013 Annual Meeting Abstracts
- Page 370 and 371:
ARVO 2013 Annual Meeting Abstracts
- Page 372 and 373:
ARVO 2013 Annual Meeting Abstracts
- Page 374 and 375:
ARVO 2013 Annual Meeting Abstracts
- Page 376 and 377:
ARVO 2013 Annual Meeting Abstracts
- Page 378 and 379:
ARVO 2013 Annual Meeting Abstracts
- Page 380 and 381:
ARVO 2013 Annual Meeting Abstracts
- Page 382 and 383:
ARVO 2013 Annual Meeting Abstracts